Papa is delivering as advertised. 2017 is the rebound. Fingers crossed that 13 is the bottom.
VRX Valeant Pharmaceuticals
- Thread starter Hemant Verma
- Start date
Asset sales mostly go to paying debts, cash on hand $660-800M (Millions), whereas huge debt still @ $30.5B (Billions), that's why down
Has anyone an idea what is the market value of Brodalumab psoriasis drug alone (3b potential revenue)?
vrx lower today even as market rages higher. Ackman seen on ledge of 344 Broadway skyscraper, talking him down now.
From Google Business Summary, Fundamentals looked really ugly:
Total Assets=$46B, $17B of which was Goodwill; they overpaid their acquisitions.
Total Liability=$40B, $30B of which was Long Term Debt, $5B comes due in the next 18 m.
Operating Cash Flow ~$2B, probably not enough to cover interest payment let alone debt repayment.
Stock price too low and difficult to use as currency, so needs to keep selling assets, shrinking company.
Looks like a company in a downward spiral. I have no dog in this fight, I just hope the new CEO can find a way to stop the spiral and reverse the fall.
Reminded me of Rite Aid a few years ago. For Rite Aid, the latest CEO managed to right the ship and the business survived. Shareholders however took a big haircut and the stock price today is still only ~10% of its peak back in 1999.
Best wishes to all.